Abstract
• Levodopa‐Carbidopa Intestinal Gel infusion (LCIG) in advanced stages of Parkinson's Disease is proven to significantly reduce motor fluctuations and dyskinesia compared to oral levodopa. • It is a very complex therapy requiring a lot of effort from the healthcare staff and a close collaboration between neurologists and gastroenterologists. • Complications with the procedure and with the device are common, presenting in more than 60% of patients. • A lot of complications will be solved improving the devices used for the endoscopic procedures, the better maintenance of the skin around the stoma and greater interaction among patients, caregivers and healthcare professionals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
